1 asset in RAD51D-Related Cancer Predisposition
Therapeutic assets addressing RAD51D-Related Cancer Predisposition, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Tamoxifen RAD51D-Related Cancer Predisposition | European Institute of Oncology | P2 | CCC (53) |